We came across a bullish thesis on AbCellera Biologics Inc. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.'s share was trading at $3.6200 as of January 21st. ABCL’s trailing P/E was 19.92 according to Yahoo Finance.
[caption id="attachment_615403" align="aligncenter" width="750"]AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. ABCL is transitioning into a critical...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.